CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.
about
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities.CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer.β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer.Keap1-MCM3 interaction is a potential coordinator of molecular machineries of antioxidant response and genomic DNA replication in metazoa
P2860
CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
CDK20 interacts with KEAP1 to ...... sistance in lung cancer cells.
@en
CDK20 interacts with KEAP1 to ...... sistance in lung cancer cells.
@nl
type
label
CDK20 interacts with KEAP1 to ...... sistance in lung cancer cells.
@en
CDK20 interacts with KEAP1 to ...... sistance in lung cancer cells.
@nl
prefLabel
CDK20 interacts with KEAP1 to ...... sistance in lung cancer cells.
@en
CDK20 interacts with KEAP1 to ...... sistance in lung cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
CDK20 interacts with KEAP1 to ...... sistance in lung cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2017.161
P407
P577
2017-05-22T00:00:00Z